SORA NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Top Win International Limited · Consumer Cyclical · Luxury Goods

Open interactive chart View report data
Latest close 2.09 USD
20.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 14.6% of its 52-week range. The latest completed week returned 20.8%, after a 3.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 55/100.

Setup score 30 out of 100
Latest Close 2.09 USD 24 Jul 2026
1W Return 20.8% latest completed week
4W Return 3.0% short-term follow-through
12W Return -25.1% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 8.8x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 20.8% Latest completed week; four-week move 3.0%. Indicator stack 0/41 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 27.83% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 55/100 4 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 14.6% of its 52-week range. The latest completed week returned 20.8%, after a 3.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 8.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2012-week average 0.23

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.0% over four weeks, -25.1% over 12 weeks, and -68.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W20.8%
4W3.0%
12W-25.1%
26W-19.9%
52W-68.3%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.03Latest activity-pressure read.
Pressure change-104.6%Four-week change in activity pressure.
Leadership-42.91Latest relative-leadership reading.
RS change18.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength1/100Blend of value, momentum, and quality. Underlying universe rank 100; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum2/100Medium-term price momentum. Underlying universe rank 99; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.0x
Price divided by trailing earnings.
Price / sales
36.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
2.6%
Gross profit retained from each unit of revenue.
Operating margin
-14.3%
Operating profit retained from revenue.
Free-cash-flow margin
-39.3%
Free cash flow generated from revenue.
Return on invested capital
-4.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-17.9%
Net share repurchases relative to market value.
Shareholder yield
-17.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-8.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 4 relevant articles.

1 positive · 3 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-70.1%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2616 weeks finished lower.
Best week+23.9%Week of 24 Apr.
Worst week-32.2%Week of 30 Jan.
Latest week+20.8%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains2
Flat weeks1
Modest losses4
Sharp losses12
Recent vol9.0%13-week weekly-return volatility.
Base vol12.8%52-week weekly-return volatility.
Up/down split17/34Count of positive and negative weeks in the 52-week window.
Average skew12.3% / -8.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.20; No reversal markers Next-Week ExpectancyNegative 27.83%

Next-week expectancy is negative with a 27.83% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors3/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 90; Small Cap Core rank 95 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 4 relevant articles.

AsiaStrategy Revenue Breakdown – NASDAQ:SORA Insiders50/100

No recent insider transaction evidence is stored.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20262.09 USD20.8%2.26 USD3.83 USD-0.03-42.911.9MOff
17 Jul 20261.73 USD-8.9%2.30 USD3.86 USD0.04-54.90160.6KOff
10 Jul 20261.90 USD0.5%2.36 USD3.90 USD0.23-54.08245.9KOff
3 Jul 20261.89 USD-6.9%2.42 USD3.93 USD0.43-55.0325.4KOff
26 Jun 20262.03 USD-6.9%2.49 USD3.97 USD0.63-52.9229.8KOff
19 Jun 20262.18 USD-5.6%2.55 USD4.00 USD0.80-52.9030.9KOff
12 Jun 20262.31 USD-4.1%2.61 USD4.04 USD0.92-50.35101.7KOff
5 Jun 20262.41 USD-15.4%2.66 USD4.07 USD0.99-48.3571.8KOff
29 May 20262.85 USD8.0%2.72 USD4.10 USD1.02-43.0849.6KOff
22 May 20262.64 USD-2.9%2.80 USD4.13 USD1.01-47.8435.1KOff
15 May 20262.72 USD7.1%2.89 USD4.15 USD1.00-66.5KOff
8 May 20262.54 USD-9.0%2.96 USD4.18 USD0.96-51.6KOff
1 May 20262.79 USD0.0%3.07 USD4.22 USD0.81-37.6KOff
24 Apr 20262.79 USD23.9%3.15 USD4.25 USD0.67-171.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.